首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Journal Of Enzyme Inhibition And Medicinal Chemistry

Journal Of Enzyme Inhibition And Medicinal Chemistry杂志,由Informa Healthcare出版,于2002年创刊,Bimonthly,出版语言English,ISSN:1475-6366,E-ISSN:1475-6374。

投稿咨询
Journal Of Enzyme Inhibition And Medicinal Chemistry
Journal Of Enzyme Inhibition And Medicinal Chemistry
Journal Of Enzyme Inhibition And Medicinal Chemistry
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
2区
影响因子
5.3
CiteScore
11.9
期刊收录
SCI、SCIE

Journal Of Enzyme Inhibition And Medicinal Chemistry(中文译名:《酶抑制与药物化学杂志》),ISSN:1475-6366,EISSN:1475-6374,是Informa Healthcare出版的国际性学术期刊,创刊于2002年,以Bimonthly形式稳定发行,2026年总发文量约109篇。该刊采用OA开放访问,学科归属为医学 - 生化与分子生物学。该刊是医学、生化与分子生物学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达5.3,2025年期刊CiteScore为11.9,2025年期刊自引率约1.9%,在中科院期刊分区体系中位列医学大类2区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Journal Of Enzyme Inhibition And Medicinal Chemistry长期聚焦医学、生化与分子生物学及相关产业的技术应用前沿,平均审稿周期偏慢,4-8周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、生化与分子生物学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,ItalyCHINA MAINLAND、Egypt、South Korea、Saudi Arabia、Turkey、France等为核心发文国家与地区;UNIVERSITY OF FLORENCECONSIGLIO NAZIONALE DELLE RICERCHE (CNR)、KING SAUD UNIVERSITY、CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)、MANSOURA UNIVERSITY、NATIONAL RESEARCH CENTRE (NRC)、SAPIENZA UNIVERSITY ROME等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 CHEMISTRY, MEDICINAL 药物化学
2区 2区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 CHEMISTRY, MEDICINAL 药物化学
2区 2区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 CHEMISTRY, MEDICINAL 药物化学
2区 2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q1 79 / 328

76.1

学科:CHEMISTRY, MEDICINAL SCIE Q2 19 / 72

74.3

学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q1 46 / 328

86.13

学科:CHEMISTRY, MEDICINAL SCIE Q1 12 / 72

84.03

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q1 61 / 320

81.1

学科:CHEMISTRY, MEDICINAL SCIE Q1 12 / 72

84

学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q1 37 / 321

88.63

学科:CHEMISTRY, MEDICINAL SCIE Q1 9 / 72

88.19


中国学者近期发文

1
2H-pyrazolo[3,4-d]pyrimidin-4-amine derivatives as novel selective fibroblast growth factor receptor 2 (FGFR2) inhibitor

Author:Wu, Pinglian; Tian, Zhaodi; Shen, Weizhong; Xun, Qiuju; Tian, Yuan; Li, Huiqiong; Yang, Bowen; Chang, Shaohua; Huang, Weixue; Wang, Zhen; Ding, Ke; Ma, Dawei

Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2026; Vol. 41, Issue 1, pp. -. DOI: 10.1080/14756366.2026.2647526

2
Application of 18β-glycyrrhetinic acid Fluorescent probes in cell imagin

Author:Zhao, Yifan; Sun, Hongxia; Yan, Zhiwei; Wang, Youde; Li, Shuai; Guo, Yachun; Miao, Guangxin; Wang, Tienan; Zhang, Liying; Song, Chengjun

Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2026; Vol. 41, Issue 1, pp. -. DOI: 10.1080/14756366.2026.2631869

3
Screening of peptide inhibitors targeting YAP-TEAD4 interaction: affinity evaluation and anti-AML cell activit

Author:Yang, Xiaotian; Yang, Shudan; Lin, Guoqiang; Chen, Shutong; Jiang, Huiran; Wang, Yuting; Zhang, Yanming; Zhang, Xingxia

Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2026; Vol. 41, Issue 1, pp. -. DOI: 10.1080/14756366.2026.2633822

4
LDH isozymes as targets for cancer therap

Author:Hou, Yiqian; Zhao, Yanying; He, Qinghua; Wang, Meilin; Zhang, Qinglian

Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2026; Vol. 41, Issue 1, pp. -. DOI: 10.1080/14756366.2026.2639168

5
Drug-likeness prioritised selection identifies anti-Escherichia coli candidates confirmed by molecular docking, dynamics simulations, and antibacterial assay

Author:Yu, Beibei; Zhu, Haoyu; Xu, Lu; Zhao, Xiangdong; Shi, Wei

Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2026; Vol. 41, Issue 1, pp. -. DOI: 10.1080/14756366.2026.2640719

6
Discovery of ferulic acid carbamate derivatives as dual-targeting agents of BuChE and Nrf2 for Alzheimer's diseas

Author:Lao, Kejing; Li, Yingze; Xiao, Yueyan; Sun, Ya; Dai, Yuxuan; Li, Huijin; Yang, Yang; Zhang, Yun; Wang, Jing; Li, Weize; Gou, Xingchun; Guan, Li

Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2026; Vol. 41, Issue 1, pp. -. DOI: 10.1080/14756366.2026.2645483

7
Design, synthesis and biological evaluation of donepezil-safinamide hybrids as dual AChE and MAO-B inhibitor for Alzheimer's disease treatmen

Author:Li, Wei; Guo, Yan; Wang, Xiaoli; Yang, Chunyan; Zhu, Jiang; Cao, Zhongcheng

Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2026; Vol. 41, Issue 1, pp. -. DOI: 10.1080/14756366.2026.2622769

8
Thymol carbamates bearing cyclic amines as potent and selective BuChE inhibitors alleviate memory impairments for Alzheimer's disease therap

Author:Wu, Chengyao; Ding, Yulu; Liu, Xiaodan; Gao, Shan; Wang, Xiaoqing; Tang, Wenjian

Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2026; Vol. 41, Issue 1, pp. -. DOI: 10.1080/14756366.2026.2623314

9
Integrating virtual screening and molecular dynamics simulations to identify emodin as a PYCR1 inhibitor modulating docetaxel sensitivity in prostate cance

Author:Liu, Shuai; Lao, Yongfeng; Cheng, Long; Xiao, Xi; Ma, Longtu; Wang, Wenyun; Zhao, Kun; Li, Wenxuan; Zhou, Zhongze; Li, Qingchao; Tao, Yan; Liu, Shanhui; Dong, Zhilong

Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2026; Vol. 41, Issue 1, pp. -. DOI: 10.1080/14756366.2026.2622725

10
Diethyl Phthalate (DEP) as a potential osteosarcoma risk factor: a multi-omics study integrating network Toxicology, single-cell RNA sequencing, and molecular dockin

Author:Yin, Shangqi; Liu, Wuzheng; Gao, Chunxiao; Li, Chunyan; Wu, Jun

Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. 2026; Vol. 41, Issue 1, pp. -. DOI: 10.1080/14756366.2025.2611582


在线咨询

Journal Of Enzyme Inhibition And Medicinal Chemistry

国际简称:J ENZYM INHIB MED CH参考译名:酶抑制与药物化学杂志

年发文量:109 CiteScore:11.9 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:85.32%

杂志社联系方式:TAYLOR & FRANCIS LTD, 4 PARK SQUARE, MILTON PARK, ABINGDON, ENGLAND, OXON, OX14 4RN

Journal Of Enzyme Inhibition And Medicinal Chemistry